Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Franklin C, Mohr P, Meier F, Weichenthal M, Grimmel-Mann I, Gutzmer R, Utikal JS, Terheyden P, Herbst R, Haferkamp S, Pfohler C, Leiter-Stoppke U, Ziller F, Meiss F, Ulrich J, Kreuter A, Gebhardt C, Welzel J, Schilling B, Kaatz M, Scharfetter-Kochanek K, Dippel E, Nashan D, Sachse MM, Weishaupt C, Loffler H, Gambichler T, Loquai C, Heinzerling L, Grabbe S, Debus D, Schley G, Weyandt G, Trommer M, Lodde G, Placke JM, Zimmer L, Livingstone E, Horn S, Schadendorf D, Ugurel S (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 13-14

Conference Proceedings Title: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Franklin, C., Mohr, P., Meier, F., Weichenthal, M., Grimmel-Mann, I., Gutzmer, R.,... Ugurel, S. (2022). Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 13-14). HOBOKEN: WILEY.

MLA:

Franklin, C., et al. "Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG." Proceedings of the JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT HOBOKEN: WILEY, 2022. 13-14.

BibTeX: Download